APA (7th ed.) Citation

WZ, Y., A, V. D. W., OG, S., T, K., R, A., AG, K., . . . VG, J. (2024). Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies. Neurology(R) neuroimmunology & neuroinflammation, 11(6), e200328. https://doi.org/10.1212/NXI.0000000000200328

Chicago Style (17th ed.) Citation

WZ, Yeh, et al. "Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies." Neurology(R) Neuroimmunology & Neuroinflammation 11, no. 6 (2024): e200328. https://doi.org/10.1212/NXI.0000000000200328.

MLA (9th ed.) Citation

WZ, Yeh, et al. "Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies." Neurology(R) Neuroimmunology & Neuroinflammation, vol. 11, no. 6, 2024, p. e200328, https://doi.org/10.1212/NXI.0000000000200328.